nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—testicular cancer	0.469	0.827	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—testicular cancer	0.098	0.173	CbGbCtD
Foscarnet—Dehydration—Doxorubicin—testicular cancer	0.000382	0.000881	CcSEcCtD
Foscarnet—Paraesthesia—Cisplatin—testicular cancer	0.000381	0.00088	CcSEcCtD
Foscarnet—Thrombocytopenia—Etoposide—testicular cancer	0.000381	0.000879	CcSEcCtD
Foscarnet—Dyspnoea—Cisplatin—testicular cancer	0.000378	0.000873	CcSEcCtD
Foscarnet—Hyperhidrosis—Etoposide—testicular cancer	0.000376	0.000868	CcSEcCtD
Foscarnet—Pancreatitis—Epirubicin—testicular cancer	0.000376	0.000867	CcSEcCtD
Foscarnet—Hypokalaemia—Doxorubicin—testicular cancer	0.000373	0.000862	CcSEcCtD
Foscarnet—Anorexia—Etoposide—testicular cancer	0.000371	0.000855	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000369	0.000853	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000369	0.000853	CcSEcCtD
Foscarnet—Decreased appetite—Cisplatin—testicular cancer	0.000369	0.000852	CcSEcCtD
Foscarnet—Diarrhoea—Dactinomycin—testicular cancer	0.000368	0.000848	CcSEcCtD
Foscarnet—Vomiting—Bleomycin—testicular cancer	0.000366	0.000845	CcSEcCtD
Foscarnet—Pancytopenia—Epirubicin—testicular cancer	0.000364	0.00084	CcSEcCtD
Foscarnet—Hypotension—Etoposide—testicular cancer	0.000363	0.000839	CcSEcCtD
Foscarnet—Rash—Bleomycin—testicular cancer	0.000363	0.000838	CcSEcCtD
Foscarnet—Pain—Cisplatin—testicular cancer	0.000363	0.000838	CcSEcCtD
Foscarnet—Dermatitis—Bleomycin—testicular cancer	0.000363	0.000837	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000362	0.000836	CcSEcCtD
Foscarnet—Muscular weakness—Doxorubicin—testicular cancer	0.000362	0.000835	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000362	0.000835	CcSEcCtD
Foscarnet—Renal failure—Methotrexate—testicular cancer	0.000359	0.000828	CcSEcCtD
Foscarnet—Dysuria—Epirubicin—testicular cancer	0.000358	0.000827	CcSEcCtD
Foscarnet—Neutropenia—Epirubicin—testicular cancer	0.000358	0.000827	CcSEcCtD
Foscarnet—Conjunctivitis—Methotrexate—testicular cancer	0.000355	0.000819	CcSEcCtD
Foscarnet—Dysphagia—Doxorubicin—testicular cancer	0.000355	0.000818	CcSEcCtD
Foscarnet—Asthenia—Ifosfamide—testicular cancer	0.000353	0.000815	CcSEcCtD
Foscarnet—Feeling abnormal—Cisplatin—testicular cancer	0.00035	0.000807	CcSEcCtD
Foscarnet—Paraesthesia—Etoposide—testicular cancer	0.000349	0.000806	CcSEcCtD
Foscarnet—Pruritus—Ifosfamide—testicular cancer	0.000348	0.000804	CcSEcCtD
Foscarnet—Haematuria—Methotrexate—testicular cancer	0.000348	0.000804	CcSEcCtD
Foscarnet—Pancreatitis—Doxorubicin—testicular cancer	0.000348	0.000802	CcSEcCtD
Foscarnet—Weight decreased—Epirubicin—testicular cancer	0.000347	0.0008	CcSEcCtD
Foscarnet—Dyspnoea—Etoposide—testicular cancer	0.000347	0.0008	CcSEcCtD
Foscarnet—Somnolence—Etoposide—testicular cancer	0.000346	0.000798	CcSEcCtD
Foscarnet—Nausea—Bleomycin—testicular cancer	0.000342	0.00079	CcSEcCtD
Foscarnet—Vomiting—Dactinomycin—testicular cancer	0.000342	0.000788	CcSEcCtD
Foscarnet—Agranulocytosis—Methotrexate—testicular cancer	0.000341	0.000787	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000339	0.000782	CcSEcCtD
Foscarnet—Rash—Dactinomycin—testicular cancer	0.000339	0.000782	CcSEcCtD
Foscarnet—Decreased appetite—Etoposide—testicular cancer	0.000338	0.00078	CcSEcCtD
Foscarnet—Diarrhoea—Ifosfamide—testicular cancer	0.000337	0.000777	CcSEcCtD
Foscarnet—Pancytopenia—Doxorubicin—testicular cancer	0.000337	0.000777	CcSEcCtD
Foscarnet—Renal failure—Epirubicin—testicular cancer	0.000336	0.000775	CcSEcCtD
Foscarnet—Body temperature increased—Cisplatin—testicular cancer	0.000335	0.000774	CcSEcCtD
Foscarnet—Fatigue—Etoposide—testicular cancer	0.000335	0.000774	CcSEcCtD
Foscarnet—Neuropathy peripheral—Epirubicin—testicular cancer	0.000335	0.000773	CcSEcCtD
Foscarnet—Constipation—Etoposide—testicular cancer	0.000332	0.000767	CcSEcCtD
Foscarnet—Pain—Etoposide—testicular cancer	0.000332	0.000767	CcSEcCtD
Foscarnet—Urinary tract infection—Epirubicin—testicular cancer	0.000332	0.000767	CcSEcCtD
Foscarnet—Conjunctivitis—Epirubicin—testicular cancer	0.000332	0.000767	CcSEcCtD
Foscarnet—Dysuria—Doxorubicin—testicular cancer	0.000332	0.000765	CcSEcCtD
Foscarnet—Neutropenia—Doxorubicin—testicular cancer	0.000332	0.000765	CcSEcCtD
Foscarnet—Haematuria—Epirubicin—testicular cancer	0.000326	0.000752	CcSEcCtD
Foscarnet—Dizziness—Ifosfamide—testicular cancer	0.000326	0.000751	CcSEcCtD
Foscarnet—Pharyngitis—Methotrexate—testicular cancer	0.000325	0.000751	CcSEcCtD
Foscarnet—Urethral disorder—Methotrexate—testicular cancer	0.000321	0.000742	CcSEcCtD
Foscarnet—Weight decreased—Doxorubicin—testicular cancer	0.000321	0.000741	CcSEcCtD
Foscarnet—Sinusitis—Epirubicin—testicular cancer	0.000321	0.00074	CcSEcCtD
Foscarnet—Feeling abnormal—Etoposide—testicular cancer	0.00032	0.00074	CcSEcCtD
Foscarnet—Nausea—Dactinomycin—testicular cancer	0.000319	0.000737	CcSEcCtD
Foscarnet—Agranulocytosis—Epirubicin—testicular cancer	0.000319	0.000736	CcSEcCtD
Foscarnet—Gastrointestinal pain—Etoposide—testicular cancer	0.000318	0.000734	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000313	0.000724	CcSEcCtD
Foscarnet—Vomiting—Ifosfamide—testicular cancer	0.000313	0.000722	CcSEcCtD
Foscarnet—Renal failure—Doxorubicin—testicular cancer	0.000311	0.000717	CcSEcCtD
Foscarnet—Rash—Ifosfamide—testicular cancer	0.00031	0.000716	CcSEcCtD
Foscarnet—Dermatitis—Ifosfamide—testicular cancer	0.00031	0.000716	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—testicular cancer	0.00031	0.000715	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00031	0.000715	CcSEcCtD
Foscarnet—Rhinitis—Epirubicin—testicular cancer	0.000308	0.00071	CcSEcCtD
Foscarnet—Abdominal pain—Etoposide—testicular cancer	0.000307	0.000709	CcSEcCtD
Foscarnet—Body temperature increased—Etoposide—testicular cancer	0.000307	0.000709	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—testicular cancer	0.000307	0.000709	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—testicular cancer	0.000307	0.000709	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—testicular cancer	0.000306	0.000707	CcSEcCtD
Foscarnet—Hypoaesthesia—Epirubicin—testicular cancer	0.000305	0.000705	CcSEcCtD
Foscarnet—Asthenia—Cisplatin—testicular cancer	0.000304	0.000703	CcSEcCtD
Foscarnet—Pharyngitis—Epirubicin—testicular cancer	0.000304	0.000703	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—testicular cancer	0.000301	0.000696	CcSEcCtD
Foscarnet—Urethral disorder—Epirubicin—testicular cancer	0.000301	0.000694	CcSEcCtD
Foscarnet—Sinusitis—Doxorubicin—testicular cancer	0.000297	0.000685	CcSEcCtD
Foscarnet—Agranulocytosis—Doxorubicin—testicular cancer	0.000295	0.000681	CcSEcCtD
Foscarnet—Chills—Methotrexate—testicular cancer	0.000294	0.000679	CcSEcCtD
Foscarnet—Nausea—Ifosfamide—testicular cancer	0.000292	0.000675	CcSEcCtD
Foscarnet—Diarrhoea—Cisplatin—testicular cancer	0.00029	0.00067	CcSEcCtD
Foscarnet—Erythema multiforme—Epirubicin—testicular cancer	0.00029	0.000669	CcSEcCtD
Foscarnet—Eye disorder—Epirubicin—testicular cancer	0.000287	0.000662	CcSEcCtD
Foscarnet—Flushing—Epirubicin—testicular cancer	0.000285	0.000657	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—testicular cancer	0.000285	0.000657	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—testicular cancer	0.000282	0.000652	CcSEcCtD
Foscarnet—Pharyngitis—Doxorubicin—testicular cancer	0.000282	0.00065	CcSEcCtD
Foscarnet—Asthenia—Etoposide—testicular cancer	0.000279	0.000644	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—testicular cancer	0.000278	0.000642	CcSEcCtD
Foscarnet—Back pain—Methotrexate—testicular cancer	0.000276	0.000637	CcSEcCtD
Foscarnet—Chills—Epirubicin—testicular cancer	0.000275	0.000635	CcSEcCtD
Foscarnet—Pruritus—Etoposide—testicular cancer	0.000275	0.000635	CcSEcCtD
Foscarnet—Vomiting—Cisplatin—testicular cancer	0.00027	0.000623	CcSEcCtD
Foscarnet—Erythema multiforme—Doxorubicin—testicular cancer	0.000268	0.000619	CcSEcCtD
Foscarnet—Rash—Cisplatin—testicular cancer	0.000268	0.000618	CcSEcCtD
Foscarnet—Dermatitis—Cisplatin—testicular cancer	0.000267	0.000617	CcSEcCtD
Foscarnet—Diarrhoea—Etoposide—testicular cancer	0.000266	0.000614	CcSEcCtD
Foscarnet—Eye disorder—Doxorubicin—testicular cancer	0.000265	0.000612	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—testicular cancer	0.000265	0.000611	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—testicular cancer	0.000264	0.000609	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—testicular cancer	0.000263	0.000608	CcSEcCtD
Foscarnet—Flatulence—Epirubicin—testicular cancer	0.000263	0.000607	CcSEcCtD
Foscarnet—Tension—Epirubicin—testicular cancer	0.000262	0.000605	CcSEcCtD
Foscarnet—Nervousness—Epirubicin—testicular cancer	0.000259	0.000599	CcSEcCtD
Foscarnet—Back pain—Epirubicin—testicular cancer	0.000258	0.000596	CcSEcCtD
Foscarnet—Malaise—Methotrexate—testicular cancer	0.000257	0.000594	CcSEcCtD
Foscarnet—Dizziness—Etoposide—testicular cancer	0.000257	0.000593	CcSEcCtD
Foscarnet—Muscle spasms—Epirubicin—testicular cancer	0.000257	0.000593	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—testicular cancer	0.000255	0.00059	CcSEcCtD
Foscarnet—Chills—Doxorubicin—testicular cancer	0.000255	0.000588	CcSEcCtD
Foscarnet—Nausea—Cisplatin—testicular cancer	0.000252	0.000582	CcSEcCtD
Foscarnet—Cough—Methotrexate—testicular cancer	0.000249	0.000575	CcSEcCtD
Foscarnet—Ill-defined disorder—Epirubicin—testicular cancer	0.000248	0.000572	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—testicular cancer	0.000247	0.000571	CcSEcCtD
Foscarnet—Vomiting—Etoposide—testicular cancer	0.000247	0.000571	CcSEcCtD
Foscarnet—Anaemia—Epirubicin—testicular cancer	0.000247	0.00057	CcSEcCtD
Foscarnet—Agitation—Epirubicin—testicular cancer	0.000245	0.000566	CcSEcCtD
Foscarnet—Rash—Etoposide—testicular cancer	0.000245	0.000566	CcSEcCtD
Foscarnet—Dermatitis—Etoposide—testicular cancer	0.000245	0.000565	CcSEcCtD
Foscarnet—Headache—Etoposide—testicular cancer	0.000244	0.000562	CcSEcCtD
Foscarnet—Flatulence—Doxorubicin—testicular cancer	0.000243	0.000562	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—testicular cancer	0.000243	0.000561	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—testicular cancer	0.000243	0.000561	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—testicular cancer	0.000243	0.000561	CcSEcCtD
Foscarnet—Tension—Doxorubicin—testicular cancer	0.000242	0.00056	CcSEcCtD
Foscarnet—Malaise—Epirubicin—testicular cancer	0.000241	0.000556	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—testicular cancer	0.00024	0.000554	CcSEcCtD
Foscarnet—Nervousness—Doxorubicin—testicular cancer	0.00024	0.000554	CcSEcCtD
Foscarnet—Leukopenia—Epirubicin—testicular cancer	0.000239	0.000552	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—testicular cancer	0.000239	0.000552	CcSEcCtD
Foscarnet—Muscle spasms—Doxorubicin—testicular cancer	0.000238	0.000548	CcSEcCtD
Foscarnet—Palpitations—Epirubicin—testicular cancer	0.000236	0.000545	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—testicular cancer	0.000235	0.000542	CcSEcCtD
Foscarnet—Cough—Epirubicin—testicular cancer	0.000233	0.000538	CcSEcCtD
Foscarnet—Convulsion—Epirubicin—testicular cancer	0.000231	0.000534	CcSEcCtD
Foscarnet—Infection—Methotrexate—testicular cancer	0.000231	0.000534	CcSEcCtD
Foscarnet—Nausea—Etoposide—testicular cancer	0.000231	0.000533	CcSEcCtD
Foscarnet—Hypertension—Epirubicin—testicular cancer	0.000231	0.000532	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—testicular cancer	0.000229	0.000529	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—testicular cancer	0.000228	0.000527	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—testicular cancer	0.000228	0.000526	CcSEcCtD
Foscarnet—Chest pain—Epirubicin—testicular cancer	0.000227	0.000525	CcSEcCtD
Foscarnet—Arthralgia—Epirubicin—testicular cancer	0.000227	0.000525	CcSEcCtD
Foscarnet—Myalgia—Epirubicin—testicular cancer	0.000227	0.000525	CcSEcCtD
Foscarnet—Agitation—Doxorubicin—testicular cancer	0.000227	0.000524	CcSEcCtD
Foscarnet—Anxiety—Epirubicin—testicular cancer	0.000227	0.000523	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—testicular cancer	0.000225	0.00052	CcSEcCtD
Foscarnet—Discomfort—Epirubicin—testicular cancer	0.000225	0.000518	CcSEcCtD
Foscarnet—Malaise—Doxorubicin—testicular cancer	0.000223	0.000514	CcSEcCtD
Foscarnet—Dry mouth—Epirubicin—testicular cancer	0.000222	0.000513	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—testicular cancer	0.000222	0.000512	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—testicular cancer	0.000221	0.00051	CcSEcCtD
Foscarnet—Confusional state—Epirubicin—testicular cancer	0.00022	0.000507	CcSEcCtD
Foscarnet—Palpitations—Doxorubicin—testicular cancer	0.000218	0.000504	CcSEcCtD
Foscarnet—Oedema—Epirubicin—testicular cancer	0.000218	0.000503	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—testicular cancer	0.000218	0.000502	CcSEcCtD
Foscarnet—Infection—Epirubicin—testicular cancer	0.000217	0.0005	CcSEcCtD
Foscarnet—Cough—Doxorubicin—testicular cancer	0.000216	0.000498	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—testicular cancer	0.000214	0.000494	CcSEcCtD
Foscarnet—Thrombocytopenia—Epirubicin—testicular cancer	0.000213	0.000493	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—testicular cancer	0.000213	0.000492	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000212	0.00049	CcSEcCtD
Foscarnet—Hyperhidrosis—Epirubicin—testicular cancer	0.000211	0.000486	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—testicular cancer	0.000211	0.000486	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—testicular cancer	0.00021	0.000486	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—testicular cancer	0.00021	0.000486	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—testicular cancer	0.00021	0.000486	CcSEcCtD
Foscarnet—Anxiety—Doxorubicin—testicular cancer	0.00021	0.000484	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—testicular cancer	0.000209	0.000483	CcSEcCtD
Foscarnet—Discomfort—Doxorubicin—testicular cancer	0.000208	0.00048	CcSEcCtD
Foscarnet—Anorexia—Epirubicin—testicular cancer	0.000208	0.00048	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—testicular cancer	0.000208	0.000479	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—testicular cancer	0.000207	0.000478	CcSEcCtD
Foscarnet—Dry mouth—Doxorubicin—testicular cancer	0.000206	0.000475	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—testicular cancer	0.000205	0.000473	CcSEcCtD
Foscarnet—Hypotension—Epirubicin—testicular cancer	0.000204	0.00047	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—testicular cancer	0.000203	0.000469	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—testicular cancer	0.000202	0.000467	CcSEcCtD
Foscarnet—Oedema—Doxorubicin—testicular cancer	0.000202	0.000465	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—testicular cancer	0.000201	0.000463	CcSEcCtD
Foscarnet—Infection—Doxorubicin—testicular cancer	0.0002	0.000462	CcSEcCtD
Foscarnet—Pain—Methotrexate—testicular cancer	0.000199	0.00046	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000199	0.000458	CcSEcCtD
Foscarnet—Thrombocytopenia—Doxorubicin—testicular cancer	0.000197	0.000456	CcSEcCtD
Foscarnet—Insomnia—Epirubicin—testicular cancer	0.000197	0.000455	CcSEcCtD
Foscarnet—Paraesthesia—Epirubicin—testicular cancer	0.000196	0.000452	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—testicular cancer	0.000195	0.00045	CcSEcCtD
Foscarnet—Dyspnoea—Epirubicin—testicular cancer	0.000194	0.000448	CcSEcCtD
Foscarnet—Somnolence—Epirubicin—testicular cancer	0.000194	0.000447	CcSEcCtD
Foscarnet—Anorexia—Doxorubicin—testicular cancer	0.000192	0.000444	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—testicular cancer	0.000192	0.000443	CcSEcCtD
Foscarnet—Dyspepsia—Epirubicin—testicular cancer	0.000192	0.000443	CcSEcCtD
Foscarnet—Gastrointestinal pain—Methotrexate—testicular cancer	0.00019	0.00044	CcSEcCtD
Foscarnet—Decreased appetite—Epirubicin—testicular cancer	0.000189	0.000437	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—testicular cancer	0.000188	0.000435	CcSEcCtD
Foscarnet—Fatigue—Epirubicin—testicular cancer	0.000188	0.000434	CcSEcCtD
Foscarnet—Pain—Epirubicin—testicular cancer	0.000186	0.00043	CcSEcCtD
Foscarnet—Constipation—Epirubicin—testicular cancer	0.000186	0.00043	CcSEcCtD
Foscarnet—Abdominal pain—Methotrexate—testicular cancer	0.000184	0.000425	CcSEcCtD
Foscarnet—Body temperature increased—Methotrexate—testicular cancer	0.000184	0.000425	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000184	0.000424	CcSEcCtD
Foscarnet—Insomnia—Doxorubicin—testicular cancer	0.000182	0.000421	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—testicular cancer	0.000181	0.000418	CcSEcCtD
Foscarnet—Dyspnoea—Doxorubicin—testicular cancer	0.00018	0.000415	CcSEcCtD
Foscarnet—Feeling abnormal—Epirubicin—testicular cancer	0.00018	0.000415	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—testicular cancer	0.000179	0.000414	CcSEcCtD
Foscarnet—Gastrointestinal pain—Epirubicin—testicular cancer	0.000178	0.000411	CcSEcCtD
Foscarnet—Dyspepsia—Doxorubicin—testicular cancer	0.000178	0.00041	CcSEcCtD
Foscarnet—Decreased appetite—Doxorubicin—testicular cancer	0.000175	0.000405	CcSEcCtD
Foscarnet—Fatigue—Doxorubicin—testicular cancer	0.000174	0.000401	CcSEcCtD
Foscarnet—Constipation—Doxorubicin—testicular cancer	0.000172	0.000398	CcSEcCtD
Foscarnet—Pain—Doxorubicin—testicular cancer	0.000172	0.000398	CcSEcCtD
Foscarnet—Abdominal pain—Epirubicin—testicular cancer	0.000172	0.000398	CcSEcCtD
Foscarnet—Body temperature increased—Epirubicin—testicular cancer	0.000172	0.000398	CcSEcCtD
Foscarnet—Asthenia—Methotrexate—testicular cancer	0.000167	0.000386	CcSEcCtD
Foscarnet—Feeling abnormal—Doxorubicin—testicular cancer	0.000166	0.000384	CcSEcCtD
Foscarnet—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000165	0.000381	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—testicular cancer	0.000165	0.00038	CcSEcCtD
Foscarnet—Body temperature increased—Doxorubicin—testicular cancer	0.000159	0.000368	CcSEcCtD
Foscarnet—Abdominal pain—Doxorubicin—testicular cancer	0.000159	0.000368	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—testicular cancer	0.000159	0.000368	CcSEcCtD
Foscarnet—Asthenia—Epirubicin—testicular cancer	0.000156	0.000361	CcSEcCtD
Foscarnet—Pruritus—Epirubicin—testicular cancer	0.000154	0.000356	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—testicular cancer	0.000154	0.000355	CcSEcCtD
Foscarnet—Diarrhoea—Epirubicin—testicular cancer	0.000149	0.000344	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—testicular cancer	0.000148	0.000342	CcSEcCtD
Foscarnet—Rash—Methotrexate—testicular cancer	0.000147	0.000339	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—testicular cancer	0.000147	0.000339	CcSEcCtD
Foscarnet—Headache—Methotrexate—testicular cancer	0.000146	0.000337	CcSEcCtD
Foscarnet—Asthenia—Doxorubicin—testicular cancer	0.000145	0.000334	CcSEcCtD
Foscarnet—Dizziness—Epirubicin—testicular cancer	0.000144	0.000333	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—testicular cancer	0.000143	0.000329	CcSEcCtD
Foscarnet—Vomiting—Epirubicin—testicular cancer	0.000139	0.00032	CcSEcCtD
Foscarnet—Nausea—Methotrexate—testicular cancer	0.000138	0.000319	CcSEcCtD
Foscarnet—Diarrhoea—Doxorubicin—testicular cancer	0.000138	0.000318	CcSEcCtD
Foscarnet—Rash—Epirubicin—testicular cancer	0.000137	0.000317	CcSEcCtD
Foscarnet—Dermatitis—Epirubicin—testicular cancer	0.000137	0.000317	CcSEcCtD
Foscarnet—Headache—Epirubicin—testicular cancer	0.000137	0.000315	CcSEcCtD
Foscarnet—Dizziness—Doxorubicin—testicular cancer	0.000133	0.000308	CcSEcCtD
Foscarnet—Nausea—Epirubicin—testicular cancer	0.000129	0.000299	CcSEcCtD
Foscarnet—Vomiting—Doxorubicin—testicular cancer	0.000128	0.000296	CcSEcCtD
Foscarnet—Rash—Doxorubicin—testicular cancer	0.000127	0.000293	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—testicular cancer	0.000127	0.000293	CcSEcCtD
Foscarnet—Headache—Doxorubicin—testicular cancer	0.000126	0.000292	CcSEcCtD
Foscarnet—Nausea—Doxorubicin—testicular cancer	0.00012	0.000276	CcSEcCtD
